Basic Study
Copyright ©The Author(s) 2017.
World J Cardiol. Apr 26, 2017; 9(4): 320-331
Published online Apr 26, 2017. doi: 10.4330/wjc.v9.i4.320
Table 1 The disease enrichment analysis
DiseaseGene No.Adjusted value
Cardiovascular diseases594.38E-05
Heart diseases500.0002
Vascular diseases490.0003
Cardiovascular abnormalities270.0003
Bradycardia90.0067
congenital long QT syndrome60.0094
Metaplasia260.0094
Cerebrovascular disorders250.0094
Arrhythmias, cardiac190.0094
Syncope120.0094
Romano-ward syndrome60.0094
Neovascularization, pathologic240.0094
Atrial fibrillation140.0094
Glycogen storage disease80.0097
Myocardial ischemia340.0097
Glycogen storage disease, type IV50.0181
Heart murmurs40.0207
Congenital abnormalities610.0207
Adhesion640.0207
Heart defects, congenital170.0207
Ventricular dysfunction140.0207
Atrioventricular block nitrous oxide system80.0264
Heart block110.0315
Parkinson disease180.0450
Mesothelioma100.0450
Coronary artery disease310.0450
Stress500.0450
Coronary disease310.0450
Jervell-lange nielsen syndrome40.0450
Table 2 The significantly enriched gene pathways
Pathway nameNo. GeneAdjusted value
Insulin signaling pathway289.47E-06
Endocytosis330.0003
Hypertrophic cardiomyopathy150.0171
Arrhythmogenic right ventricular cardiomyopathy130.0385
Extracellular matrix-receptor interaction140.0445
Focal adhesion240.0462
Prostate cancer140.0462
Tryptophan metabolism90.0462
Pathways in cancer350.0462
MAPK signaling pathway300.0462
Table 3 Differentially expressed proteins identified by MALDI MS-MS
No.Protein codeGene IDKI/WTKO/WTKO/KIPathways
1PKP1187721.76-1.13-1.99Focal adhesion, apoptosis
2HRC154641.621.06-1.53Calcium signaling
4PYGB533131.611.16-1.39Glucagon signaling, insulin signaling
5MSN117698-2.684.7112.57Cell shape, actin-cytoskeleton
6VINC22330-4.184.9620.64Cell-cell adhesion, cell shape, actin cytoskeleton
8SYNE1164009-3.595.8220.82Nucleus-cytoskeleton connection
14ADAM10114871.71-1.18-2.02Inflammation, amiloidosis
17TNPO3320938-1.111.511.67Nucleus-cytoskeleton connection
18CAPN81707252.15-1.02-2.19Inflammation
19CGNL1681781.58-1.03-1.63Focal adhesion
20VIM223521.431.40-1.02Cell division, fibrosis
23MYH6178881.02-3.41-3.49Sarcomere, actin-cytoskeleton
24NRAP18175-1.031.791.84Focal adhesion, actin cytoskeleton
28ANXA3204801.23-1.80-2.23Prostaglandin synthesis and regulation
29LATS223805-1.58-1.511.04Hippo signaling pathway, DNA damage
32SPTB1207411.56-1.01-1.59Actin-cytoskeleton
33GCC2114261.04-3.78-3.92Vesicle-mediated transport, retrograde transport at the trans-Golgi-network
37ACADS12306-2.011.122.24Mitochondrial fatty acid beta-oxidation
39FHL2142001.05-2.25-2.37Focal adhesion, Wnt, calcineurin signaling
39MYOZ2590061.05-2.25-2.37Cytoskeleton, calcineurin signaling, myofibrillogenesis
47FGF9141802.935.902.01Fibrosis
53DST135182.231.01-2.21Focal adhesion, actin cytoskeleton
59FEZ2560691.89-1.11-2.12N/A
59CSRP3130091.89-1.11-2.12Stress sensing, myogenesis
62MYOM1319565-1.371.582.15Striated muscle contraction
63MYOM217930+++Sarcomere
65EZR/MSN17698+++Cell surface organization, adhesion, microtubule
Table 4 Genes whose gene expression has significant correlation with Mypn and gene product have significant change comparing with KI or KO mice
Protein codeCorr P valueKI/WTKO/WTKO/KI
CGNL10.00241.58-1.03-1.63
PKP10.00821.76-1.13-1.99
SYNE110.0114-3.595.8220.82
PYGB0.01571.611.16-1.39
MSN0.0194-2.684.7112.57
ANXA30.03191.23-1.8-2.23
MYOM110.0335-1.371.582.15
ACADS0.035-2.011.122.24
GCC20.03751.04-3.78-3.92
FEZ20.03991.89-1.11-2.12
LATS20.0431-1.58-1.511.04